Displaying 1 - 20 of 225
Amphastar Pharmaceuticals Inc.
Date Sent
File
Warning Letter to Amphastar Pharmaceuticals Inc.
(173.09 KB)
FTC Renews Challenge of More Than 200 Improper Patent Listings
Date
Continuing its efforts to promote competition and lower drug prices, today the Federal Trade Commission renewed its challenges against dozens of improperly listed device patents that shield brand-name...
Novartis Pharmaceuticals Corp.
Date Sent
File
Warning Letter to Novartis Pharmaceuticals Corp.
(175.19 KB)
Federal Trade Commission Statement Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book
Date
Matter Number
P233900
File
Text of the Policy Statement
(633.47 KB)
Federal Register Notice
Amgen Inc. and Horizon Therapeutics plc; Analysis of Agreement Containing Consent Order To Aid Public Comment
Date
Displaying 1 - 20 of 225